Regeneron Pharmaceuticals (REGN) Q1 2025 Earnings

4FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
9.55
10.52
11.49
12.46

Details

Expected EPS
11.282238
Actual EPS
12.07
Surprise EPS
0.79
Surprise Percent
+6.98%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 12.07 per share for Q1 2025.

0 Comments

Share your thoughts